FDA advisory committee

Cancelled
Pharma

FDA cancels adcomm for Cabometyx in neuroendocrine tumors

Exelixis’ original announcement about a planned adcomm meeting came as somewhat of a surprise given positive findings from a phase 3 trial.
Angus Liu Jan 10, 2025 9:46am
FDA

More testing needed after Moderna trial halted by FDA: experts

Dec 13, 2024 8:15am
FDA

Exelixis' Cabometyx to face FDA adcomm in neuroendocrine tumors

Nov 27, 2024 11:30am
AZ

FDA raises safety flags ahead of adcomm for AZ's Andexxa

Nov 20, 2024 8:33am
Image of a neon sign with the word no lit up next to an unlit yes

FDA shoots down Intercept's bid for full approval of Ocaliva

Nov 12, 2024 2:12pm
FDA

Experts back FDA's plan to restrict PD-1 drugs in GI cancers

Sep 26, 2024 1:38pm